|
End-of-day quote
Shanghai S.E.
2026-08-17
|
5-day change | 1st Jan Change | ||
| 3.930 CNY | +1.29% |
|
+4.80% | -1.26% |
| Market Cap | 3.08B 457M 395M 371M 338M 635M 43.72B 644M 4.35B 1.7B 21.89B 1.72B 1.68B 72.93B | P/E 2024 |
-8.86x | P/E 2025 | -9.48x |
|---|---|---|---|---|---|
| Enterprise Value | 3.3B 490M 423M 397M 362M 679M 46.8B 689M 4.66B 1.82B 23.43B 1.84B 1.8B 78.06B | EV / Sales 2024 |
1.48x | EV / Sales 2025 | 1.79x |
| Free-Float |
68.56% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.29% | ||
| 1 week | +4.80% | ||
| Current month | +10.39% | ||
| 1 month | +8.86% | ||
| 3 months | +0.26% | ||
| 6 months | -2.00% | ||
| Current year | -1.26% |
| 1 week | 3.7 |  | 4.1 |
| 1 month | 3.15 | | 4.1 |
| Current year | 2.85 | | 5.27 |
| 1 year | 2.85 | | 5.27 |
| 3 years | 2.76 | | 6.15 |
| 5 years | 2.76 | | 8.8 |
| 10 years | 2.76 | | 20.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ya Qi Dou
CEO | Chief Executive Officer | 42 | 2021-05-12 |
Xianti Zeng
DFI | Director of Finance/CFO | 52 | 2024-09-05 |
Zhi Wei Wang
PRN | Corporate Officer/Principal | 56 | 2019-09-16 |
| Director | Title | Age | Since |
|---|---|---|---|
Qi Ling Dou
CHM | Chairman | 66 | 2009-01-21 |
Zhi Wei Wang
BRD | Director/Board Member | 56 | 2011-02-20 |
Ya Qi Dou
BRD | Director/Board Member | 42 | 2019-01-02 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.29% | +4.80% | -5.98% | -28.02% | 451M | |
| +0.25% | -0.22% | +68.73% | +116.60% | 1,052B | |
| +0.78% | +1.21% | +48.53% | +52.20% | 627B | |
| +0.35% | +1.74% | +21.11% | +65.18% | 441B | |
| +0.28% | -3.05% | +39.10% | +36.65% | 349B | |
| +0.78% | -2.05% | +24.03% | +36.97% | 287B | |
| +0.87% | -2.82% | -0.28% | +6.27% | 241B | |
| +1.00% | +2.05% | +41.46% | +58.24% | 224B | |
| -0.78% | -4.16% | -10.28% | -53.87% | 202B | |
| +0.40% | +4.29% | +17.36% | +78.10% | 172B | |
| Average | +0.52% | -0.43% | +24.38% | +36.83% | 359.56B | |
| Weighted average by Cap. | +0.44% | -0.63% | +39.70% | +62.48% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.17B 323M 279M 262M 238M 448M 30.84B 454M 3.07B 1.2B 15.44B 1.21B 1.18B 51.43B | 1.86B 276M 239M 224M 204M 384M 26.42B 389M 2.63B 1.03B 13.23B 1.04B 1.02B 44.07B |
| Net income | -317M -47.07M -40.66M -38.17M -34.76M -65.32M -4.5B -66.26M -448M -175M -2.25B -177M -173M -7.5B | -330M -48.9M -42.24M -39.65M -36.11M -67.86M -4.67B -68.84M -465M -182M -2.34B -184M -180M -7.8B |
| Net Debt | 411M 60.97M 52.66M 49.44M 45.02M 84.6M 5.83B 85.83M 580M 227M 2.92B 229M 224M 9.72B | 217M 32.22M 27.83M 26.12M 23.79M 44.71M 3.08B 45.35M 306M 120M 1.54B 121M 118M 5.14B |
Employees
4,832
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-17 | CN¥3.930 | +1.29% | 36,016,200 |
| 26-08-14 | CN¥3.880 | -1.02% | 31,661,635 |
| 26-08-13 | CN¥3.920 | +1.03% | 53,938,879 |
| 26-08-12 | CN¥3.880 | +1.31% | 41,702,400 |
| 26-08-11 | CN¥3.830 | +1.32% | 52,795,126 |
- Stock Market
- Stocks
- 600594 Stock
Select your edition
All financial news and data tailored to specific country editions
